Please Wait

Applying Filters...

Drug Product Composition: Vancomycin Sulfate

Vancomycin Sulfate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

43 API Suppliers, 20 USDMF, 16 CEP/COS, 8 JDMF, 1 EU WC, 13 KDMF, 20 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

FINISHED DOSAGE FORMULATIONS

322 FDF Dossiers, 142 FDA Orange Book, 76 Europe, 27 Canada, 10 Australia, 13 South Africa, 54 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 1.25GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 1.5GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 1.75GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INTRAVENOUS - EQ 2GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 750MG BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 10GM BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 1GM BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 500MG BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 5GM BASE/VIAL, CAPSULE;ORAL - EQ 125MG BASE, CAPSULE;ORAL - EQ 250MG BASE

RELATED EXCIPIENT COMPANIES

2 Seqens, 7 DKSH, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 6 Actylis, 14 BASF, 2 Finar, 2 Gangwal Chemicals, 3 Lonza Capsugel, 2 Nomisma Healthcare, 1 Pluviaendo, 1 Qualicaps, 6 Roquette, 1 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Topical, 9 Thickeners and Stabilizers, 9 Coating Systems & Additives, 8 Parenteral, 8 Empty Capsules, 6 Film Formers & Plasticizers, 6 Fillers, Diluents & Binders, 6 Solubilizers, 5 Controlled & Modified Release, 4 Granulation, 3 Lubricants & Glidants, 3 Coloring Agents, 3 Taste Masking, 1 Surfactant & Foaming Agents, 1 Direct Compression, 1 Emulsifying Agents

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 93 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 69 Finished Drug Prices, 2 Annual Reports

MARKET PLACE

37 APIs, 20 FDF Dossiers

PATENTS & EXCLUSIVITIES

60 US Patents, 4 US Exclusivities

REF. STANDARDS & IMPURITIES

1 EDQM, 2 USP, 4 Others

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 209481 / DOSAGE - POWDER;INTRAVENOUS - EQ 1.75GM BASE/VIAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
VANCOMYCIN HYDROCHLORIDE(UNII: 71WO621TJD) (VANCOMYCIN - UNII:6Q205EH1VU)	VANCOMYCIN	750mg in 15 \| 250mg in 5 \| 1.25g in 25 \| 1.5g in 30

Drug Product Composition: Vancomycin Sulfate

Vancomycin Sulfate

Vancomycin Sulfate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

43 API Suppliers

20 USDMF

16 CEP/COS

8 JDMF

1 EU WC

13 KDMF

20 NDC API

21 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

FINISHED DOSAGE FORMULATIONS

322 FDF Dossiers

142 FDA Orange Book

76 Europe

27 Canada

10 Australia

13 South Africa

54 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 1.25GM BASE/VIAL

POWDER;INTRAVENOUS - EQ 1.5GM BASE/VIAL

POWDER;INTRAVENOUS - EQ 1.75GM BASE/VIAL

POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

POWDER;INTRAVENOUS - EQ 2GM BASE/VIAL

POWDER;INTRAVENOUS - EQ 750MG BASE/VIAL

POWDER;INTRAVENOUS, ORAL - EQ 10GM BASE/VIAL

POWDER;INTRAVENOUS, ORAL - EQ 1GM BASE/VIAL

POWDER;INTRAVENOUS, ORAL - EQ 500MG BASE/VIAL

POWDER;INTRAVENOUS, ORAL - EQ 5GM BASE/VIAL

CAPSULE;ORAL - EQ 125MG BASE

CAPSULE;ORAL - EQ 250MG BASE

RELATED EXCIPIENT COMPANIES

2 Seqens

7 DKSH

2 Nanjing Well Pharmaceutical

4 ACG Worldwide

6 Actylis

14 BASF

2 Finar

2 Gangwal Chemicals

3 Lonza Capsugel

2 Nomisma Healthcare

1 Pluviaendo

1 Qualicaps

6 Roquette

1 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Topical

9 Thickeners and Stabilizers

9 Coating Systems & Additives

8 Parenteral

8 Empty Capsules

6 Film Formers & Plasticizers

6 Fillers, Diluents & Binders

6 Solubilizers

5 Controlled & Modified Release

4 Granulation

3 Lubricants & Glidants

3 Coloring Agents

3 Taste Masking

1 Surfactant & Foaming Agents

1 Direct Compression

1 Emulsifying Agents

DIGITAL CONTENT

POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons